1 active not recruiting, 1 completed. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Active not recruiting 1, Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow brexanolone: new trials by email Literature Review of brexanolone trials Research Report on brexanolone
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Utility of Brexanolone to Target Stress-induced Alcohol Use Among Men and Women With Posttraumatic Stress Disorder Brexanolone - PTSD, Alcohol Use Disorder | Phase 1 | Active not recruiting | Yale University | 25 | 2023-08-01 | 2025-10-14 |
| Study to Evaluate SAGE-547 Injection as Adjunctive Therapy for the Treatment of Super-Refractory Status Epilepticus SAGE-547 - Super-refractory Status Epilepticus | Phase 1 / Phase 2 | Completed | Supernus Pharmaceuticals, Inc. | 25 | 2014-03-21 | 2025-09-15 |
Alcoholism (1) · Status Epilepticus (1) · Stress Disorders, Post-Traumatic (1)
Supernus Pharmaceuticals, Inc. (1) · Yale University (1)
United States (2)
MacKenzie R Peltier, PhD (1) · Robert Lasser, MD, MBA (1)
U54AA027989 (1)